Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Exponent (EXPO) Consolidated Net Income: 2010-2025

Historic Consolidated Net Income for Exponent (EXPO) over the last 16 years, with Oct 2025 value amounting to $28.0 million.

  • Exponent's Consolidated Net Income rose 7.68% to $28.0 million in Q4 2025 from the same period last year, while for Oct 2025 it was $101.5 million, marking a year-over-year decrease of 4.52%. This contributed to the annual value of $105.7 million for FY2025, which is 5.34% up from last year.
  • Exponent's Consolidated Net Income amounted to $28.0 million in Q4 2025, which was up 5.62% from $26.6 million recorded in Q3 2025.
  • Exponent's 5-year Consolidated Net Income high stood at $30.8 million for Q2 2021, and its period low was $14.4 million during Q4 2021.
  • For the 3-year period, Exponent's Consolidated Net Income averaged around $26.1 million, with its median value being $26.6 million (2025).
  • Within the past 5 years, the most significant YoY rise in Exponent's Consolidated Net Income was 55.39% (2021), while the steepest drop was 27.05% (2021).
  • Quarterly analysis of 5 years shows Exponent's Consolidated Net Income stood at $14.4 million in 2021, then increased by 5.47% to $15.2 million in 2022, then spiked by 38.04% to $20.9 million in 2023, then rose by 6.14% to $26.0 million in 2024, then rose by 7.68% to $28.0 million in 2025.
  • Its last three reported values are $28.0 million in Q4 2025, $26.6 million for Q3 2025, and $26.6 million during Q2 2025.